v3.26.1
Investments
 3 Months Ended
Mar. 31, 2026
Schedule of Investments [Abstract]  
Investments Investments
Control and Affiliate Investments
As required by the 1940 Act, the Company classifies its investments by level of control. “Control investments” are defined in the 1940 Act as investments in those companies that the Company is deemed to “control”. Under the 1940 Act, the Company is generally deemed to “control” a company in which it has invested if it owns 25% or more of the voting securities of such company or has greater than 50% representation on its board. “Affiliate investments” are investments in those companies that are “affiliated companies” of the Company, as defined in the 1940 Act, which are not control investments. The Company is deemed to be an “affiliate” of a company in which it has invested if it owns 5% or more, but generally less than 25%, of the voting securities of such company. “Non-control/non-affiliate investments” are investments that are neither control investments nor affiliate investments. For purposes of determining the classification of its investments, the Company has included consideration of any voting securities or board appointment rights held by the Adviser Funds.
The following table summarizes the Company’s realized gains and losses and changes in unrealized appreciation and depreciation on control and affiliate investments for the three months ended March 31, 2026 and 2025.
(in thousands)Three Months Ended March 31, 2026
Portfolio Company(1)
TypeFair Value as of March 31, 2026Interest & Dividend Income Fee IncomeNet Change in Unrealized Appreciation (Depreciation) Realized Gain (Loss)
Control Investments
Coronado Aesthetics, LLCControl$158 $— $— $(60)$— 
Gibraltar Acquisition LLC(2)
Control62,167 1,128 35 213 — 
Hercules Adviser LLC(3)
Control44,137 2,101 — (2,137)— 
Tectura CorporationControl9,786 170 — 445 — 
Total Control Investments$116,248 $3,399 $35 $(1,539)$— 
(in thousands)Three Months Ended March 31, 2025
Portfolio Company(1)
TypeFair Value as of March 31, 2025Interest & Dividend IncomeFee IncomeNet Change in Unrealized Appreciation (Depreciation)Realized Gain (Loss)
Control Investments
Coronado Aesthetics, LLCControl$47 $— $— $(22)$— 
Gibraltar Acquisition LLC(2)
Control58,900 1,567 39 (941)— 
Hercules Adviser LLC(3)
Control45,017 1,900 — 2,827 — 
Tectura CorporationControl11,770 170 — 113 — 
Total Control Investments$115,734 $3,637 $39 $1,977 $— 
(1)In accordance with Rules 3-09, 4-08(g), and Rule 10-01(b)(1) of Regulation S-X, (“Rule 3-09”, “Rule 4-08(g)”, and “Rule 10-01(b)(1)”, respectively), the Company must determine if its unconsolidated subsidiaries are considered “significant subsidiaries”. As of March 31, 2026 and March 31, 2025, there were no unconsolidated subsidiaries that are considered “significant subsidiaries”.
(2)Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC. The subsidiary has no significant assets or liabilities, other than their equity and debt investments and equity interest in Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC, respectively.
(3)Hercules Adviser LLC is owned by Hercules Capital Management LLC and presented with Hercules Partner Holdings, LLC which are both wholly owned by the Company. Please refer to “Note 1 - Description of Business” for additional disclosure.
Portfolio Composition
The following table shows the fair value of the Company’s portfolio of investments by asset class as of March 31, 2026 and December 31, 2025:
(in thousands)March 31, 2026December 31, 2025
Investments at
Fair Value		Percentage of
Total Portfolio		Investments at
Fair Value		Percentage of
Total Portfolio
Senior Secured Debt$4,469,019 94.6%$4,209,798 94.2%
Unsecured Debt71,126 1.5%69,614 1.6%
Preferred Stock53,449 1.1%52,735 1.2%
Common Stock78,659 1.7%86,275 1.9%
Warrants42,507 0.9%41,162 0.9%
Investment Funds & Vehicles7,227 0.2%7,063 0.2%
Total$4,721,987 100.0%$4,466,647 100.0%
A summary of the Company’s investment portfolio, at value, by geographic location as of March 31, 2026 and December 31, 2025 is shown as follows:
(in thousands)March 31, 2026December 31, 2025
Investments at
Fair Value		Percentage of
Total Portfolio		Investments at
Fair Value		Percentage of
Total Portfolio
United States$4,249,172 90.0%$4,035,927 90.4%
United Kingdom152,389 3.2%118,031 2.7%
Netherlands115,004 2.4%117,344 2.6%
Israel66,148 1.4%67,280 1.5%
Germany49,417 1.1%50,386 1.1%
Switzerland47,763 1.0%35,504 0.8%
Canada18,432 0.4%16,841 0.4%
Sweden18,395 0.4%18,244 0.4%
Ireland4,770 0.1%4,729 0.1%
Singapore— 0.0%1,827 0.0%
Other(1)
497 0.0%534 0.0%
Total$4,721,987 100.0%$4,466,647 100.0 %
(1)Effective March 31, 2026, the Company’s investment portfolio based in Denmark has been consolidated with “Other”. Prior year amounts have been reclassified to conform to the current presentation.
The following table shows the fair value of the Company’s portfolio by industry sector as of March 31, 2026 and December 31, 2025:
(in thousands)March 31, 2026December 31, 2025
Investments at
Fair Value		Percentage of
Total Portfolio 		Investments at
Fair Value		Percentage of
Total Portfolio
Application Software$1,113,788 23.6%$1,087,954 24.3%
Drug Discovery & Development1,089,920 23.1%1,039,712 23.3%
Healthcare Services, Other890,720 18.9%838,508 18.8%
System Software507,172 10.7%472,144 10.6%
Consumer & Business Services474,202 10.0%449,631 10.1%
Defense Technologies157,631 3.3%140,458 3.1%
Diversified Financial Services106,304 2.3%105,896 2.4%
Medical Devices & Equipment81,619 1.7%77,257 1.7%
Electronics & Computer Hardware66,735 1.4%66,992 1.5%
Space Technologies53,167 1.1%47,816 1.1%
Consumer & Business Products42,187 0.9%8,810 0.2%
Sustainable and Renewable Technology35,804 0.8%35,759 0.8%
Communications & Networking32,063 0.7%26,263 0.6%
Information Services25,634 0.6%25,889 0.6%
Biotechnology Tools24,060 0.5%23,164 0.5%
Manufacturing Technology20,753 0.4%20,190 0.4%
Semiconductors187 0.0%158 0.0%
Media/Content/Info31 0.0%32 0.0%
Drug Delivery10 0.0%14 0.0%
Total$4,721,987 100.0%$4,466,647 100.0%
No single portfolio investment represents more than 10% of the fair value of the Company’s total investments as of March 31, 2026 or December 31, 2025.
Concentrations of Credit Risk
The Company’s customers are primarily privately held companies and public companies which are active in the “Application Software”, “Drug Discovery & Development”, “Healthcare Services, Other”, “System Software”, and “Consumer & Business Services” sectors. These sectors are characterized by high margins, high growth rates, consolidation and product and market extension opportunities. Value for companies in these sectors is often vested in intangible assets and intellectual property.
Industry and sector concentrations vary as new loans are recorded and loans are paid off. Investment income, consisting of interest, fees, and recognition of gains on equity and warrant or other equity interests, can fluctuate materially when a loan is paid off or a related warrant or equity interest is sold. Investment income recognized in any given year can be highly concentrated among several portfolio companies.
As of March 31, 2026 and December 31, 2025, the Company’s ten largest portfolio companies represented approximately 26.2% and 28.6%, respectively, of the total fair value of the Company’s investments in portfolio companies. As of March 31, 2026 and December 31, 2025, the Company had seven portfolio companies each, respectively, that represented 5% or more of the Company’s net assets. As of March 31, 2026, the Company had two equity investments which represented approximately 49.2% of the total fair value of the Company's equity investments, and each represented 5% or more of the total fair value of the Company’s equity investments. As of December 31, 2025, the Company had two equity investments which represented approximately 48.4% of the total fair value of the Company’s equity investments, and each represented 5% or more of the total fair value of the Company’s equity investments.
Investment Collateral
In the majority of cases, the Company collateralizes its investments by obtaining a first priority security interest in a portfolio company’s assets, which may include its intellectual property. In other cases, the Company may obtain a negative
pledge covering a company’s intellectual property. The Company's investments were collateralized as follows as of March 31, 2026 and December 31, 2025:
Percentage of debt investments (at fair value), as of
March 31, 2026December 31, 2025
Senior Secured First Lien
All assets including intellectual property72.6 %72.8 %
All assets with negative pledge on intellectual property9.1 %9.5 %
“Last-out” with security interest in all of the assets6.9 %7.0 %
Total senior secured first lien position88.6 %89.3 %
Second lien9.8 %9.1 %
Unsecured1.6 %1.6 %
Total debt investments at fair value100.0 %100.0 %
Derivative Instruments
The Company enters into forward currency contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. The following is a summary of the fair value and location of the Company’s derivative instruments in the Consolidated Statements of Assets and Liabilities held as of March 31, 2026 and December 31, 2025:
(in thousands)Fair Value
Derivative InstrumentStatement LocationMarch 31, 2026December 31, 2025
Foreign currency forward contractOther assets$522 $50 
Total$522 $50 
Net realized and unrealized gains and losses on derivative instruments recorded by the Company during the three months ended March 31, 2026 and 2025 are in the following locations in the Consolidated Statements of Operations:
(in thousands) Three Months Ended March 31,
Derivative InstrumentStatement Location20262025
Foreign currency forward contractNet change in unrealized appreciation (depreciation) - Non-control / Non-affiliate investments$472 $(840)
 Total$472 $(840)
Investment Income
The Company’s investment portfolio generates interest, fee, and dividend income. The composition of the Company’s interest income and fee income is as follows:
(in thousands)Three Months Ended March 31,
 20262025
Contractual interest income$104,082 $87,817 
Exit fee interest income14,698 10,228 
PIK interest income12,914 13,473 
Dividend income2,100 2,400 
Other investment income(1)
2,609 1,654 
Total interest and dividend income$136,403 $115,572 
Recurring fee income$2,912 $2,680 
Fee income - expired commitments563 317 
Accelerated fee income - early repayments1,658 942 
Total fee income$5,133 $3,939 
(1)Other investment income includes OID interest income and interest recorded on other assets.
As of March 31, 2026 and December 31, 2025, unamortized capitalized fee income was recorded as follows:
(in millions)March 31,
2026		December 31,
2025
Offset against debt investment cost$43.6 $42.5 
Deferred obligation contingent on funding or other milestone11.5 9.8 
Total Unamortized Fee Income$55.1 $52.3 
As of March 31, 2026 and December 31, 2025, loan exit fees receivable were recorded as follows:
(in millions)March 31,
2026		December 31,
2025
Included within debt investment cost$49.5 $48.6 
Deferred receivable related to expired commitments5.9 4.5 
Total Exit Fees Receivable$55.4 $53.1